Tevogen Bio Holdings Inc (NASDAQ: TVGN): Think Like A Lender, Not An Investor

Tevogen Bio Holdings Inc (NASDAQ:TVGN) currently has a daily average trading volume of 3.80M but it saw 3048688 shares traded in last market. With a market cap of 253.82M USD, the company’s current market price of $1.45 came falling about -5.23 while comparing to the previous closing price of $1.53. In past 52 weeks, the stock remained buoying in the range of price level as high as $21.09 and as low as $0.26. In the recent trading on the day, stock has struck highest price mark of $1.38 while lowest mark touched by it was $1.65.

Taking a look at 20-day trading activity of Tevogen Bio Holdings Inc (TVGN) gives us an average price of $1.3130, while its current price level is -93.12% below from 52-week high level whereas it is 467.29% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.2324 while that of 200 days or SMA-200 reads an average of $1.0100. A closer look into the stock’s movement over the week reveals that its volatility is standing at 19.81% during that period while stretching the period over a month that decreases to 14.38%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 55.77 which implies that the stock is in neutral territory.

Over the week, TVGN’s stock price is moving 7.41% up while it is 38.10% when we observe its performance for the past one month. Year-to-date it is 40.78% up and over the past year, the stock is showing a downside performance of -80.87%.

The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.

Currently, Tevogen Bio Holdings Inc’s total number of outstanding shares is 170.77M with 93.39% of that held by the insiders while 3.82% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -124.74%. Stock’s beta reads -1.09. Its return on asset (ROA) is -14.86% on average.